Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
The promoter region of the human BUBR1 gene and its expression analysis in lung cancerMasahiro Seike, Akihiko Gemma, Yoko Hosoya, et al.
Molecular Cancer Therapeutics|July 9, 2008
Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive modelAkihiko Miyanaga, Akihiko Gemma, Rintaro Noro, et al.
Anticancer Research|October 13, 2012
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancerAkinobu Yoshimura, Rintaro Noro, Akihiko Miyanaga, et al.
Respiratory Medicine Case Reports|October 1, 2024
Pulmonary Mycobacterium avium complex infection with vascular Ehlers-Danlos syndrome: A case reportKen Okamura, Rintaro Noro, Toru Tanaka, et al.
International Journal of Oncology|October 4, 2007
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitorsRintaro Noro, Akihiko Gemma, Akihiko Miyanaga, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2025
Prognostic impact of HNF4α expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitorHirokazu Iso, Ryo Ariyasu, Syunsuke Fujishima, et al.
Internal Medicine (Tokyo, Japan)|January 15, 2023
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic CarcinomaErika Mikami, Shinji Nakamichi, Atsuhiro Nagano, et al.
Clinical Lung Cancer|February 27, 2023
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS)Akihiko Miyanaga, Hajime Asahina, Satoshi Watanabe, et al.
Cancer Medicine|June 26, 2024
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathwayYasuhiro Kato, Masaru Matsumoto, Natsuki Takano, et al.
Clinical Lung Cancer|November 17, 2020
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)Hajime Asahina, Kentaro Tanaka, Satoshi Morita, et al.
Pageof 25